Type 2 diabetes and technology
Continuous glucose monitoring (CGM) in persons with type 2 diabetes receiving insulin.
Development of guidelines
Making a guideline for timing and frequency of self-measured blood glucose (SMBG) in persons with type 2 diabetes receiving insulin.
Aim: To investigate the effectivity of the use of CGM on time in range and HbA1c for persons with type 2 diabetes receiving insulin
Collaborators: The type 2 outpatient clinic at SDCC and DexCom Corp.
Aim: To test a new app solution for type 2 diabetes management and communication between patient and HCP.
Collaborators: DTU, CFD. The project is part of an EU funded project: 'Integrated Personalized Diabetes Management Goes Europe' (iPDM-GO).